These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The spectrum of polymyositis and dermatomyositis. Pearson CM; Bohan A Med Clin North Am; 1977 Mar; 61(2):439-57. PubMed ID: 323599 [No Abstract] [Full Text] [Related]
6. Combination immunosuppressive treatment of steroid-resistant dermatomyositis/polymyositis. Wallace DJ; Metzger AL; White KK Arthritis Rheum; 1985 May; 28(5):590-2. PubMed ID: 4004968 [No Abstract] [Full Text] [Related]
7. [Interstitial pulmonary involvement of polymyositis and dermatomyositis. Apropos of 3 cases. Review of the literature]. Flammang d'Ortho MP; Cadranel J; Milleron B; Zalcman G; Arvin-Berod C; Terrioux P; Akoun G Rev Pneumol Clin; 1991; 47(1):29-36. PubMed ID: 1882159 [TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. al-Janadi M; Smith CD; Karsh J J Rheumatol; 1989 Dec; 16(12):1592-6. PubMed ID: 2625692 [TBL] [Abstract][Full Text] [Related]
9. Polymyositis-dermatomyositis:25 years of follow-up of 50 patients disease course, treatment, prognostic factors. Chwalińska-Sadowska H; Małdykowa H Mater Med Pol; 1990; 22(3):213-8. PubMed ID: 2132429 [TBL] [Abstract][Full Text] [Related]
11. History and classification of polymyositis and dermatomyositis. Bohan A Clin Dermatol; 1988; 6(2):3-8. PubMed ID: 3293742 [No Abstract] [Full Text] [Related]
12. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Bohan A; Peter JB; Bowman RL; Pearson CM Medicine (Baltimore); 1977 Jul; 56(4):255-86. PubMed ID: 327194 [No Abstract] [Full Text] [Related]
13. [ACTH-prednisone-penicillin in the treatment of dermatomyositis with generalized interstitial calcinosis]. Schmidt-Peter P; Pfeil B Helv Paediatr Acta; 1966 Jun; 21(2):178-88. PubMed ID: 4295642 [No Abstract] [Full Text] [Related]
14. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Marie I; Hatron PY; Levesque H; Hachulla E; Hellot MF; Michon-Pasturel U; Courtois H; Devulder B Medicine (Baltimore); 1999 May; 78(3):139-47. PubMed ID: 10352646 [TBL] [Abstract][Full Text] [Related]
15. Polymyositis with pulmonary infiltrate and pleural effusion. Roach DG; Salter WM Minn Med; 1980 Apr; 63(4):277-9, 281. PubMed ID: 7382984 [No Abstract] [Full Text] [Related]
16. Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. Danieli MG; Gambini S; Pettinari L; Logullo F; Veronesi G; Gabrielli A Autoimmun Rev; 2014 Oct; 13(10):1048-54. PubMed ID: 25183232 [TBL] [Abstract][Full Text] [Related]
17. Refractory calcinosis in a patient with dermatomyositis: response to intravenous immune globulin. Shahani L BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22907859 [TBL] [Abstract][Full Text] [Related]
18. The relationship of dermatomyositis and polymyositis to internal malignancy. Callen JP; Hyla JF; Bole GG; Kay DR Arch Dermatol; 1980 Mar; 116(3):295-8. PubMed ID: 7369745 [TBL] [Abstract][Full Text] [Related]
19. Therapy for dermatomyositis and polymyositis. Rowland LP; Clark C; Olarte M Adv Neurol; 1977; 17():63-97. PubMed ID: 888742 [No Abstract] [Full Text] [Related]
20. Dermatomyositis and polymyositis update on current controversies. Callen JP Australas J Dermatol; 1987 Aug; 28(2):62-7. PubMed ID: 3452311 [No Abstract] [Full Text] [Related] [Next] [New Search]